UNASSIGNED: This study sought to evaluate the short-term and 3-year outcomes of @entity736 -covered stent (PCS) for @entity1 with coronary perforation. Implantation of a PCS has improved the immediate clinical outcomes of @entity1 with coronary perforation. However, there are few reports regarding long-term outcomes. We evaluated a total of 57 @entity1 who were treated with PCS for coronary perforation from April 2004 to March 2015 at a single high-volume center in Japan. Landmark analysis was performed at 30 days to determine short-term and long-term outcomes. Major adverse @entity299 (MACE) were defined as death, @entity583 , target vessel revascularization, and requirement for surgical repair. Of 285 @entity1 who experienced coronary perforation, 57 @entity1 (20%) were treated with PCS. The MACE rates were 28% at 30 days, 22% at 1 year, and 38% at 3  years. 30-day MACE was mainly driven by high rates of @entity583 (18%) and surgical repair (16%). The rates of @entity75 revascularization were 8% and 12% at 1 and 3  years, respectively. Definite stent @entity715 was reported in 2 @entity1 during the follow-up period. In conclusion, despite the relatively high incidence of MACE during early stage of follow-up, implantation of a PCS provides acceptable late clinical outcomes.

Short-Term and Long-Term Outcomes After XXXX -Covered Stent Implantation for the Treatment of Coronary Perforation.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity583 :: ('MESH:D009203', 'Disease') :: ['myocardial infarction'] @entity75 :: ('MESH:D001927', 'Disease') :: ['target lesion'] @entity299 :: ('MESH:D006331', 'Disease') :: ['cardiac events'] @entity736 :: ('CHEBI:53251', 'Chemical') :: ['polytetrafluoroethylene'] @entity715 :: ('MESH:D013927', 'Disease') :: ['thrombosis']
@entity736 :: (CHEBI:53251,Chemical) :: ['Polytetrafluoroethylene']
